[English] 日本語

- EMDB-52999: HER2/ErbB2 extracellular domain (ECD) from a near full-length con... -
+
Open data
-
Basic information
Entry | ![]() | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | HER2/ErbB2 extracellular domain (ECD) from a near full-length construct solubilized in amphipols. | |||||||||
![]() | Refined full map (used for model validation | |||||||||
![]() |
| |||||||||
![]() | Receptor / tyrosine kinase / transmembrane / HER2 / SIGNALING PROTEIN | |||||||||
Function / homology | ![]() negative regulation of immature T cell proliferation in thymus / ERBB3:ERBB2 complex / ERBB2-ERBB4 signaling pathway / GRB7 events in ERBB2 signaling / immature T cell proliferation in thymus / RNA polymerase I core binding / semaphorin receptor complex / regulation of microtubule-based process / ErbB-3 class receptor binding / motor neuron axon guidance ...negative regulation of immature T cell proliferation in thymus / ERBB3:ERBB2 complex / ERBB2-ERBB4 signaling pathway / GRB7 events in ERBB2 signaling / immature T cell proliferation in thymus / RNA polymerase I core binding / semaphorin receptor complex / regulation of microtubule-based process / ErbB-3 class receptor binding / motor neuron axon guidance / Sema4D induced cell migration and growth-cone collapse / PLCG1 events in ERBB2 signaling / ERBB2-EGFR signaling pathway / neurotransmitter receptor localization to postsynaptic specialization membrane / ERBB2 Activates PTK6 Signaling / enzyme-linked receptor protein signaling pathway / neuromuscular junction development / ERBB2-ERBB3 signaling pathway / positive regulation of Rho protein signal transduction / Drug-mediated inhibition of ERBB2 signaling / Resistance of ERBB2 KD mutants to trastuzumab / Resistance of ERBB2 KD mutants to sapitinib / Resistance of ERBB2 KD mutants to tesevatinib / Resistance of ERBB2 KD mutants to neratinib / Resistance of ERBB2 KD mutants to osimertinib / Resistance of ERBB2 KD mutants to afatinib / Resistance of ERBB2 KD mutants to AEE788 / Resistance of ERBB2 KD mutants to lapatinib / Drug resistance in ERBB2 TMD/JMD mutants / positive regulation of transcription by RNA polymerase I / positive regulation of MAP kinase activity / ERBB2 Regulates Cell Motility / semaphorin-plexin signaling pathway / oligodendrocyte differentiation / PI3K events in ERBB2 signaling / positive regulation of protein targeting to membrane / regulation of angiogenesis / regulation of ERK1 and ERK2 cascade / Schwann cell development / Downregulation of ERBB2:ERBB3 signaling / coreceptor activity / Signaling by ERBB2 / TFAP2 (AP-2) family regulates transcription of growth factors and their receptors / myelination / transmembrane receptor protein tyrosine kinase activity / GRB2 events in ERBB2 signaling / positive regulation of cell adhesion / SHC1 events in ERBB2 signaling / basal plasma membrane / cell surface receptor protein tyrosine kinase signaling pathway / Constitutive Signaling by Overexpressed ERBB2 / cellular response to epidermal growth factor stimulus / bioluminescence / peptidyl-tyrosine phosphorylation / positive regulation of translation / positive regulation of epithelial cell proliferation / generation of precursor metabolites and energy / neuromuscular junction / phosphatidylinositol 3-kinase/protein kinase B signal transduction / wound healing / Signaling by ERBB2 TMD/JMD mutants / Downregulation of ERBB2 signaling / receptor protein-tyrosine kinase / Signaling by ERBB2 ECD mutants / Signaling by ERBB2 KD Mutants / receptor tyrosine kinase binding / cellular response to growth factor stimulus / ruffle membrane / epidermal growth factor receptor signaling pathway / neuron differentiation / Constitutive Signaling by Aberrant PI3K in Cancer / transmembrane signaling receptor activity / PIP3 activates AKT signaling / myelin sheath / heart development / presynaptic membrane / RAF/MAP kinase cascade / PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling / positive regulation of cell growth / protein tyrosine kinase activity / basolateral plasma membrane / early endosome / cell surface receptor signaling pathway / endosome membrane / cell population proliferation / protein phosphorylation / receptor complex / positive regulation of MAPK cascade / intracellular signal transduction / apical plasma membrane / protein heterodimerization activity / signaling receptor binding / negative regulation of apoptotic process / perinuclear region of cytoplasm / signal transduction / nucleoplasm / ATP binding / identical protein binding / nucleus / membrane Similarity search - Function | |||||||||
Biological species | ![]() ![]() ![]() | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 3.77 Å | |||||||||
![]() | Gragera M / Buschiazzo A / Vacca S | |||||||||
Funding support | European Union, 1 items
| |||||||||
![]() | ![]() Title: Structural analysis of HER2-trastuzumab complex reveals receptor conformational adaptation. Authors: Santiago Vacca / Marcos Gragera / Alejandro Buschiazzo / David Herreros / James M Krieger / Santiago Bonn-Garcia / Roberto Melero / Carlos Os Sorzano / Jose M Carazo / Ohad Medalia / Andreas Plückthun / ![]() ![]() ![]() Abstract: Human epidermal growth factor receptor-2 (HER2) is a receptor tyrosine kinase, associated with a variety of malignant tumors, usually through overexpression, resulting in aberrant signaling. ...Human epidermal growth factor receptor-2 (HER2) is a receptor tyrosine kinase, associated with a variety of malignant tumors, usually through overexpression, resulting in aberrant signaling. Trastuzumab (TZB), one of the monoclonal antibodies (mAbs) used in combination with chemotherapy, has become a major therapeutic for HER2-overexpressing cancers. Current structural understanding of HER2 and its interactions with other receptors and with different affinity agents has relied on numerous structures of individual domains of HER2. Here, we subjected purified near full-length HER2 to single-particle cryo-electron microscopy (cryo-EM) analysis. Besides the canonical conformation described in previous structural studies, we report a previously unreported conformation of the HER2 extracellular domain that is stabilized upon TZB binding, which might hamper association with HER3, a receptor with which HER2 forms an oncogenic unit. Together, our findings provide insights into the conformational dynamics of the HER2 receptor and the mechanism of action of TZB. | |||||||||
History |
|
-
Structure visualization
Supplemental images |
---|
-
Downloads & links
-EMDB archive
Map data | ![]() | 15.1 MB | ![]() | |
---|---|---|---|---|
Header (meta data) | ![]() ![]() | 25.1 KB 25.1 KB | Display Display | ![]() |
FSC (resolution estimation) | ![]() | 7.1 KB | Display | ![]() |
Images | ![]() | 81.7 KB | ||
Masks | ![]() | 30.5 MB | ![]() | |
Filedesc metadata | ![]() | 7.6 KB | ||
Others | ![]() ![]() ![]() ![]() | 27.4 MB 17.1 MB 28.3 MB 28.3 MB | ||
Archive directory | ![]() ![]() | HTTPS FTP |
-Validation report
Summary document | ![]() | 662.1 KB | Display | ![]() |
---|---|---|---|---|
Full document | ![]() | 661.6 KB | Display | |
Data in XML | ![]() | 13 KB | Display | |
Data in CIF | ![]() | 18.1 KB | Display | |
Arichive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
Related structure data | ![]() 9qbhMC ![]() 9qbfC ![]() 9qbgC M: atomic model generated by this map C: citing same article ( |
---|---|
Similar structure data | Similarity search - Function & homology ![]() |
-
Links
EMDB pages | ![]() ![]() |
---|---|
Related items in Molecule of the Month |
-
Map
File | ![]() | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Refined full map (used for model validation | ||||||||||||||||||||||||||||||||||||
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 1.302 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Mask #1
File | ![]() | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-Additional map: Refined Full map sharpened with deepEMhancer
File | emd_52999_additional_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Refined Full map sharpened with deepEMhancer | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Additional map: Refined Full map sharpened with relion post-process
File | emd_52999_additional_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Refined Full map sharpened with relion post-process | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: #2
File | emd_52999_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: #1
File | emd_52999_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-
Sample components
-Entire : HER2/ErbB2 extracellular domain (ECD) from a near full-length con...
Entire | Name: HER2/ErbB2 extracellular domain (ECD) from a near full-length construct solubilized in amphipols. |
---|---|
Components |
|
-Supramolecule #1: HER2/ErbB2 extracellular domain (ECD) from a near full-length con...
Supramolecule | Name: HER2/ErbB2 extracellular domain (ECD) from a near full-length construct solubilized in amphipols. type: complex / ID: 1 / Parent: 0 / Macromolecule list: all Details: The final reconstruction contains only the HER2 ECD. |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 112 KDa |
-Macromolecule #1: Receptor tyrosine-protein kinase erbB-2,Green fluorescent protein
Macromolecule | Name: Receptor tyrosine-protein kinase erbB-2,Green fluorescent protein type: protein_or_peptide / ID: 1 Details: Only the extracellular domain (residues from Q24 to C544) of the molecule was solved in the cryo-EM map,Only the extracellular domain (residues from Q24 to C544) of the molecule was solved ...Details: Only the extracellular domain (residues from Q24 to C544) of the molecule was solved in the cryo-EM map,Only the extracellular domain (residues from Q24 to C544) of the molecule was solved in the cryo-EM map,Only the extracellular domain (residues from Q24 to C544) of the molecule was solved in the cryo-EM map,Only the extracellular domain (residues from Q24 to C544) of the molecule was solved in the cryo-EM map.,Only the extracellular domain (residues from Q24 to C544) of the molecule was solved in the cryo-EM map,Only the extracellular domain (residues from Q24 to C544) of the molecule was solved in the cryo-EM map,Only the extracellular domain (residues from Q24 to C544) of the molecule was solved in the cryo-EM map,Only the extracellular domain (residues from Q24 to C544) of the molecule was solved in the cryo-EM map. Number of copies: 1 / Enantiomer: LEVO / EC number: receptor protein-tyrosine kinase |
---|---|
Source (natural) | Organism: ![]() ![]() |
Molecular weight | Theoretical: 146.737172 KDa |
Recombinant expression | Organism: ![]() ![]() |
Sequence | String: MKFLVNVALV FMVVYISYIY ADYKDDDDKH HHHHHHHHHL EVLFQGPYPY DVPDYATQVC TGTDMKLRLP ASPETHLDML RHLYQGCQV VQGNLELTYL PTNASLSFLQ DIQEVQGYVL IAHNQVRQVP LQRLRIVRGT QLFEDNYALA VLDNGDPLNN T TPVTGASP ...String: MKFLVNVALV FMVVYISYIY ADYKDDDDKH HHHHHHHHHL EVLFQGPYPY DVPDYATQVC TGTDMKLRLP ASPETHLDML RHLYQGCQV VQGNLELTYL PTNASLSFLQ DIQEVQGYVL IAHNQVRQVP LQRLRIVRGT QLFEDNYALA VLDNGDPLNN T TPVTGASP GGLRELQLRS LTEILKGGVL IQRNPQLCYQ DTILWKDIFH KNNQLALTLI DTNRSRACHP CSPMCKGSRC WG ESSEDCQ SLTRTVCAGG CARCKGPLPT DCCHEQCAAG CTGPKHSDCL ACLHFNHSGI CELHCPALVT YNTDTFESMP NPE GRYTFG ASCVTACPYN YLSTDVGSCT LVCPLHNQEV TAEDGTQRCE KCSKPCARVC YGLGMEHLRE VRAVTSANIQ EFAG CKKIF GSLAFLPESF DGDPASNTAP LQPEQLQVFE TLEEITGYLY ISAWPDSLPD LSVFQNLQVI RGRILHNGAY SLTLQ GLGI SWLGLRSLRE LGSGLALIHH NTHLCFVHTV PWDQLFRNPH QALLHTANRP EDECVGEGLA CHQLCARGHC WGPGPT QCV NCSQFLRGQE CVEECRVLQG LPREYVNARH CLPCHPECQP QNGSVTCFGP EADQCVACAH YKDPPFCVAR CPSGVKP DL SYMPIWKFPD EEGACQPCPI NCTHSCVDLD DKGCPAEQRA SPLTSIISAV VGILLVVVLG VVFGILIKRR QQKIRKYT M RRLLQETELV EPLTPSGAMP NQAQMRILKE TELRKVKVLG SGAFGTVYKG IWIPDGENVK IPVAIKVLRE NTSPKANKE ILDEAYVMAG VGSPYVSRLL GISLTSTVQL VTQLMPYGSL LDHVRENRGR LGSQDLLNWC MQIAKGMSYL EDVRLVHRDL AARNVLVKS PNHVKITDFG LARLLDIDET EYHADGGKVP IKWMALESIL RRRFTHQSDV WSYGVTVWEL MTFGAKPYDG I PAREIPDL LEKGERLPQP PICTIDVYMI MVKCWMIDSE SRPRFRELVS EFSRMARDPQ RFVVIQNEDL GPASPLDSTF YR SLLEDDD MGDLVDAEEY LVPQQGLEVL FQGPGSMSKG EELFTGVVPI LVELDGDVNG HKFSVRGEGE GDATNGKLTL KFI CTTGKL PVPWPTLVTT LTYGVQCFSR YPDHMKRHDF FKSAMPEGYV QERTISFKDD GTYKTRAEVK FEGDTLVNRI ELKG IDFKE DGNILGHKLE YNFNSHNVYI TADKQKNGIK ANFKIRHNVE DGSVQLADHY QQNTPIGDGP VLLPDNHYLS TQSVL SKDP NEKRDHMVLL EFVTAAGITH GMDELYK UniProtKB: Receptor tyrosine-protein kinase erbB-2, Green fluorescent protein |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
![]() | single particle reconstruction |
Aggregation state | particle |
-
Sample preparation
Buffer | pH: 7.5 |
---|---|
Grid | Model: Quantifoil R1.2/1.3 / Material: GOLD / Mesh: 200 / Support film - Material: CARBON / Support film - topology: HOLEY / Pretreatment - Type: GLOW DISCHARGE |
Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 277.15 K / Instrument: FEI VITROBOT MARK IV |
-
Electron microscopy
Microscope | TFS KRIOS |
---|---|
Specialist optics | Energy filter - Name: GIF Bioquantum / Energy filter - Slit width: 20 eV |
Image recording | Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) / Number grids imaged: 2 / Number real images: 15271 / Average exposure time: 1.2 sec. / Average electron dose: 72.3 e/Å2 |
Electron beam | Acceleration voltage: 300 kV / Electron source: ![]() |
Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal defocus max: 2.4 µm / Nominal defocus min: 0.8 µm / Nominal magnification: 130000 |
Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN |
Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
+
Image processing
-Atomic model buiding 1
Initial model | PDB ID: Chain - Source name: PDB / Chain - Initial model type: experimental model |
---|---|
Software | Name: ![]() |
Refinement | Space: REAL / Protocol: RIGID BODY FIT / Target criteria: Cross-correlation coefficient |
Output model | ![]() PDB-9qbh: |